ADAR1 Capital Management »

Bluebird Bio shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Bluebird Bio (BLUE) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Bluebird Bio

Tip: Access up to 7 years of quarterly data

All positions including Bluebird Bio held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bluebird Bio by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.4k 5.0k 1.28

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Bluebird Bio

BlackRock
BlackRock
Vanguard Group
Geode Capital Management
State Street Corporation
Avidity Partners Management
Northern Trust
Bank of America Corporation
ExodusPoint Capital Management
Renaissance Technologies
Masters Capital Mgmt
Two Sigma Investments
Two Sigma Advisers
Susquehanna International
Lion Point Capital

View all funds holding Bluebird Bio